Convergence Financial’s Thermo Fisher Scientific TMO Stock Holding History

Convergence Financial’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.36M	Sell	4,698 -58	-1%	-$27.8K	0.19%	78
2026 Q1	$2.34M	Buy	4,756 +2,343	+97%	+$1.27M	0.25%	63
2025 Q4	$1.4M	Buy	2,413 +89	+4%	+$50.3K	0.2%	67
2025 Q3	$1.13M	Sell	2,324 -25	-1%	-$11.6K	0.17%	75
2025 Q2	$952K	Sell	2,349 -915	-28%	-$383K	0.16%	78
2025 Q1	$1.62M	Buy	3,264 +219	+7%	+$119K	0.32%	53
2024 Q4	$1.58M	Buy	3,045 +103	+4%	+$56.6K	0.32%	48
2024 Q3	$1.82M	Buy	2,942 +692	+31%	+$410K	0.39%	42
2024 Q2	$1.24M	Buy	+2,250	New	+$1.29M	0.33%	40

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Convergence Financial's TMO Position: Q2 2026 in Review

Convergence Financial reduced its Thermo Fisher Scientific (TMO) stake by 1.2% in Q2 2026, selling an estimated $27.8K and leaving 4,698 shares worth $2.36M. The position accounts for 0.19% of the portfolio, ranked #78.

Convergence Financial first reported a position in TMO in Q2 2024 and has held it in 9 quarters since. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Convergence Financial held 4,698 shares of Thermo Fisher Scientific worth $2.36M as of Q2 2026.
Convergence Financial sold 58 Thermo Fisher Scientific shares in Q2 2026, an estimated $27.8K.
Thermo Fisher Scientific made up 0.19% of Convergence Financial's portfolio in Q2 2026, its #78 holding.
Convergence Financial first reported a position in Thermo Fisher Scientific in Q2 2024 and has held it in 9 quarters since.
2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Convergence Financial's 13F filing for Q2 2026, filed 5 Aug 2026.